US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 60.300
  • -0.790-1.29%
Trading Oct 18 11:20 ET
2.26BMarket Cap-11754P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
37K
83K
151K
143K
8K
0
0
0
0
0
Operating revenue
--37K
--83K
--151K
--143K
--8K
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.11%50.48M
24.95%48.57M
55.69%167.69M
38.29%44.2M
78.35%43.29M
51.13%41.34M
61.11%38.87M
40.85%107.71M
28.53%31.96M
20.17%24.27M
Selling and administrative expenses
13.15%9.96M
32.53%10.31M
26.55%34.83M
28.37%9.11M
31.87%9.15M
18.21%8.8M
28.60%7.78M
29.04%27.53M
17.57%7.09M
29.30%6.94M
-General and administrative expense
13.15%9.96M
32.53%10.31M
26.55%34.83M
28.37%9.11M
31.87%9.15M
18.21%8.8M
28.60%7.78M
29.04%27.53M
17.57%7.09M
29.30%6.94M
Research and development costs
24.53%40.52M
23.05%38.26M
55.00%135.26M
50.77%37.49M
62.27%34.14M
39.74%32.53M
71.98%31.09M
58.25%87.27M
32.04%24.87M
41.85%21.04M
Other operating expenses
----
----
66.11%-2.4M
----
----
----
----
---7.08M
--0
---3.71M
Operating profit
-22.02%-50.44M
-24.73%-48.48M
-55.55%-167.54M
-37.84%-44.06M
-78.32%-43.28M
-51.13%-41.34M
-61.11%-38.87M
-91.06%-107.71M
-556.80%-31.96M
-20.17%-24.27M
Net non-operating interest income expense
0
0
0
75.00%-1K
0
0
Non-operating interest expense
----
----
--0
--0
--0
----
----
-75.00%1K
--0
--0
Other net income (expense)
35.23%5.18M
75.17%5.37M
380.01%14.55M
70.03%3.81M
403.94%3.84M
4,355.81%3.83M
5,294.92%3.07M
951.40%3.03M
3,129.73%2.24M
656.20%762K
Gain on sale of security
34.89%5.38M
86.99%5.81M
304.91%14.76M
----
----
--3.99M
--3.11M
13,396.30%3.64M
----
----
Other non- operating income (expenses)
-26.45%-196K
-992.50%-437K
66.39%-206K
-680.53%-10.94M
403.94%3.84M
-280.23%-155K
32.20%-40K
-60.05%-613K
-1,288.12%-1.4M
656.20%762K
Income before tax
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-84.51%-104.68M
-501.46%-29.72M
-15.61%-23.51M
Income tax
0
0
Net income
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
-15.82%-23.51M
Net income continuous Operations
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
-15.82%-23.51M
Minority interest income
Net income attributable to the parent company
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
-15.82%-23.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.8M
-78.20%-104.68M
-328.21%-29.72M
-15.82%-23.51M
Basic earnings per share
1.57%-1.25
3.97%-1.21
-25.30%-5.2
-22.94%-1.34
-44.57%-1.33
-12.39%-1.27
-24.75%-1.26
-64.68%-4.15
-263.33%-1.09
-5.75%-0.92
Diluted earnings per share
1.57%-1.25
3.97%-1.21
-25.30%-5.2
-22.94%-1.34
-44.57%-1.33
-12.39%-1.27
-24.75%-1.26
-64.68%-4.15
-263.33%-1.09
-5.75%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 37K83K151K143K8K00000
Operating revenue --37K--83K--151K--143K--8K--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.11%50.48M24.95%48.57M55.69%167.69M38.29%44.2M78.35%43.29M51.13%41.34M61.11%38.87M40.85%107.71M28.53%31.96M20.17%24.27M
Selling and administrative expenses 13.15%9.96M32.53%10.31M26.55%34.83M28.37%9.11M31.87%9.15M18.21%8.8M28.60%7.78M29.04%27.53M17.57%7.09M29.30%6.94M
-General and administrative expense 13.15%9.96M32.53%10.31M26.55%34.83M28.37%9.11M31.87%9.15M18.21%8.8M28.60%7.78M29.04%27.53M17.57%7.09M29.30%6.94M
Research and development costs 24.53%40.52M23.05%38.26M55.00%135.26M50.77%37.49M62.27%34.14M39.74%32.53M71.98%31.09M58.25%87.27M32.04%24.87M41.85%21.04M
Other operating expenses --------66.11%-2.4M-------------------7.08M--0---3.71M
Operating profit -22.02%-50.44M-24.73%-48.48M-55.55%-167.54M-37.84%-44.06M-78.32%-43.28M-51.13%-41.34M-61.11%-38.87M-91.06%-107.71M-556.80%-31.96M-20.17%-24.27M
Net non-operating interest income expense 00075.00%-1K00
Non-operating interest expense ----------0--0--0---------75.00%1K--0--0
Other net income (expense) 35.23%5.18M75.17%5.37M380.01%14.55M70.03%3.81M403.94%3.84M4,355.81%3.83M5,294.92%3.07M951.40%3.03M3,129.73%2.24M656.20%762K
Gain on sale of security 34.89%5.38M86.99%5.81M304.91%14.76M----------3.99M--3.11M13,396.30%3.64M--------
Other non- operating income (expenses) -26.45%-196K-992.50%-437K66.39%-206K-680.53%-10.94M403.94%3.84M-280.23%-155K32.20%-40K-60.05%-613K-1,288.12%-1.4M656.20%762K
Income before tax -20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-84.51%-104.68M-501.46%-29.72M-15.61%-23.51M
Income tax 00
Net income -20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M-15.82%-23.51M
Net income continuous Operations -20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M-15.82%-23.51M
Minority interest income
Net income attributable to the parent company -20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M-15.82%-23.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M-67.77%-39.44M-37.55%-37.51M-48.04%-35.8M-78.20%-104.68M-328.21%-29.72M-15.82%-23.51M
Basic earnings per share 1.57%-1.253.97%-1.21-25.30%-5.2-22.94%-1.34-44.57%-1.33-12.39%-1.27-24.75%-1.26-64.68%-4.15-263.33%-1.09-5.75%-0.92
Diluted earnings per share 1.57%-1.253.97%-1.21-25.30%-5.2-22.94%-1.34-44.57%-1.33-12.39%-1.27-24.75%-1.26-64.68%-4.15-263.33%-1.09-5.75%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data